NDC 0310-6540
BYDUREON BCise
Exenatide
BYDUREON BCise is a Subcutaneous Injection, Suspension, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Astrazeneca Pharmaceuticals Lp. The primary component is Exenatide.
| Product ID | 0310-6540_249a148a-2c5a-4411-843b-f98986d5fea6 |
| NDC | 0310-6540 |
| Product Type | Human Prescription Drug |
| Proprietary Name | BYDUREON BCise |
| Generic Name | Exenatide |
| Dosage Form | Injection, Suspension, Extended Release |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2017-12-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA209210 |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | EXENATIDE |
| Active Ingredient Strength | 2 mg/.85mL |
| Pharm Classes | GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [CS],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |